[{"uuid": "1e849e01-0098-3cfc-b445-d2a26ea3618d", "title": "Akebia Therapeutics Reports Inducement Grants Under\u00a0Nasdaq Listing Rule 5635(c)(4)", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/akebia-therapeutics-reports-inducement-grants-210500466.html", "providerPublishTime": 1738703100, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/0St4CZ_EF.BcPn4adM7zLg--~B/aD0xNzYxO3c9NDMyMTthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/849c7df46f1ea545ac15df5f8a47e6b1", "width": 4321, "height": 1761, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/7.jynKXltiEG05mL9PmQ6w--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/849c7df46f1ea545ac15df5f8a47e6b1", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AKBA"]}, {"uuid": "10256843-a870-3deb-9e32-afe10a3f8fb4", "title": "New Clinical Trial Emphasizes Joint Health Benefits of Boswellia serrata Herbal Extract Featured in Osteo Bi-Flex\u00ae", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/clinical-trial-emphasizes-joint-health-131300596.html", "providerPublishTime": 1738069980, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/QWG5wqiv_MGtZYnK.5cZ4w--~B/aD0yMTY7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/44cb012a984e9ff36d91f1e2e29521be", "width": 400, "height": 216, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/jBsHuB7Ap8w1d9_kCU_1Ug--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/44cb012a984e9ff36d91f1e2e29521be", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "00c5a277-818a-3bad-a136-28fc412b5a7a", "title": "Akebia announces \u2018multiple positive business updates\u2019", "publisher": "TipRanks", "link": "https://finance.yahoo.com/news/akebia-announces-multiple-positive-business-132806278.html", "providerPublishTime": 1736861286, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/.2OcvspZzvCzzeMPm.N5LA--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/373719bd4f9106065622fdb013c92607", "width": 192, "height": 192, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/mgr3GIr91HdofkXwyQ9rdA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/tipranks_452/373719bd4f9106065622fdb013c92607", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AKBA"]}, {"uuid": "35f027a6-238c-3755-a661-dabe6e310533", "title": "Akebia Therapeutics Announces Multiple Positive Business Updates", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/akebia-therapeutics-announces-multiple-positive-130000009.html", "providerPublishTime": 1736773200, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/TC3ZCpWljA1qxdUAc3L0mw--~B/aD0xNjM7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/0ab1720f444c3184a18a33bd946181b8", "width": 400, "height": 163, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/yq1etKy8YADSdY_AR_kE.w--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/0ab1720f444c3184a18a33bd946181b8", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AKBA"]}, {"uuid": "fd1e4425-aa07-373d-9009-584f6e8f0abc", "title": "New Strong Sell Stocks for January 3rd", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/strong-sell-stocks-january-3rd-095200399.html", "providerPublishTime": 1735897920, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/y6swp5qnudxxN4rNeiZSRA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/34fbd46b67540f3cdb50013c4a171555", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/oT.szgpX..8qoDNd9ETRpA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/34fbd46b67540f3cdb50013c4a171555", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AKBA", "KOF"]}, {"uuid": "619e1008-c671-3ef6-9020-2491e2256286", "title": "Investors in Akebia Therapeutics (NASDAQ:AKBA) have unfortunately lost 73% over the last five years", "publisher": "Simply Wall St.", "link": "https://finance.yahoo.com/news/investors-akebia-therapeutics-nasdaq-akba-122705630.html", "providerPublishTime": 1734697625, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/fZxxC7WFAddugsI0.C6IZw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305", "width": 1194, "height": 432, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/dQxIoNx1LKM.kOJYTi633A--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AKBA"]}, {"uuid": "2504bf85-ef51-3e10-8188-f5b094f77157", "title": "Akebia Therapeutics (AKBA) Reports Q3 Loss, Misses Revenue Estimates", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/akebia-therapeutics-akba-reports-q3-131510924.html", "providerPublishTime": 1730985310, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/XxozWWpdDFgGg6m0CzltLg--~B/aD02MDI7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/45c083e4721b0d0d1f6e431ec0bb5cc1", "width": 900, "height": 602, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/HGBb_w3iAqceoCyVMucmoA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/45c083e4721b0d0d1f6e431ec0bb5cc1", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AKBA"]}, {"uuid": "67a0fbfa-9f5d-39b6-a56f-a701307c6907", "title": "New Strong Sell Stocks for December 5th", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/strong-sell-stocks-december-5th-104600688.html", "providerPublishTime": 1733395560, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/rP1EV4y5.bnG6Q.bCrRgNA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/22d93c77b91a36ccc2d6a44613af467e", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/d3TGN2WJK1W6Cd3Y8QmP0w--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/22d93c77b91a36ccc2d6a44613af467e", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AKBA", "KOF"]}, {"uuid": "ad393565-c834-3258-871b-f5460e7ff979", "title": "Akebia Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/akebia-therapeutics-present-43rd-annual-130000949.html", "providerPublishTime": 1734526800, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/TC3ZCpWljA1qxdUAc3L0mw--~B/aD0xNjM7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/0ab1720f444c3184a18a33bd946181b8", "width": 400, "height": 163, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/yq1etKy8YADSdY_AR_kE.w--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/0ab1720f444c3184a18a33bd946181b8", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AKBA"]}, {"uuid": "6a93d501-fa55-3ba5-909b-fec09566dfcf", "title": "New Strong Sell Stocks for November 27th", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/strong-sell-stocks-november-27th-094200146.html", "providerPublishTime": 1732700520, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/b7YQi_HTDu1GkQZqPUqgyw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/59b208c03ab625710a229f805a232093", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/W_dXstIrgNfujttWWGqEAw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/59b208c03ab625710a229f805a232093", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AKBA", "ABG"]}, {"uuid": "5b625c9c-eabd-3291-8d76-d3c21042d417", "title": "Akebia Therapeutics, Inc. (NASDAQ:AKBA) Released Earnings Last Week And Analysts Lifted Their Price Target To US$5.50", "publisher": "Simply Wall St.", "link": "https://finance.yahoo.com/news/akebia-therapeutics-inc-nasdaq-akba-133334402.html", "providerPublishTime": 1731159214, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/fZxxC7WFAddugsI0.C6IZw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305", "width": 1194, "height": 432, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/dQxIoNx1LKM.kOJYTi633A--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/2b615bb0216a492e754128412857f305", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AKBA"]}, {"uuid": "3416e44e-eb35-32b8-914a-0899cfd2a7d0", "title": "U.S. Renal Care Enrolled First Patients in the VOICE Collaborative Clinical Trial of Vafseo\u00ae (vadadustat) for CKD Patients on Dialysis", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/u-renal-care-enrolled-first-120000445.html", "providerPublishTime": 1733227200, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/TC3ZCpWljA1qxdUAc3L0mw--~B/aD0xNjM7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/0ab1720f444c3184a18a33bd946181b8", "width": 400, "height": 163, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/yq1etKy8YADSdY_AR_kE.w--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/0ab1720f444c3184a18a33bd946181b8", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AKBA"]}, {"uuid": "2c5f9032-8130-3d15-acbd-ec5385ec2b12", "title": "High Growth Tech Stocks To Watch In December 2024", "publisher": "Simply Wall St.", "link": "https://finance.yahoo.com/news/high-growth-tech-stocks-watch-180251644.html", "providerPublishTime": 1734717771, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/IO2v6Az9Ftp5BwGxWk_U3A--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8dd43bf33c3f09b3bd16e76b99877c31", "width": 1194, "height": 432, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/w9ZxkxK11mrr5o.l0d5wwQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/8dd43bf33c3f09b3bd16e76b99877c31", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AKBA", "ALDX", "INFN"]}, {"uuid": "f0485d26-f0bb-3fe2-b3e0-ba4f9dc90d52", "title": "Akebia Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/akebia-therapeutics-reports-third-quarter-120000116.html", "providerPublishTime": 1730980800, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/TC3ZCpWljA1qxdUAc3L0mw--~B/aD0xNjM7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/0ab1720f444c3184a18a33bd946181b8", "width": 400, "height": 163, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/yq1etKy8YADSdY_AR_kE.w--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/0ab1720f444c3184a18a33bd946181b8", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AKBA"]}, {"uuid": "e9e2e6d5-28e4-3be7-8bdf-f1925fa87f84", "title": "Vadadustat Alternative Dosing Study Results Published in the American Journal of Kidney Disease", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/vadadustat-alternative-dosing-study-results-130000941.html", "providerPublishTime": 1731589200, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/TC3ZCpWljA1qxdUAc3L0mw--~B/aD0xNjM7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/0ab1720f444c3184a18a33bd946181b8", "width": 400, "height": 163, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/yq1etKy8YADSdY_AR_kE.w--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/0ab1720f444c3184a18a33bd946181b8", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AKBA"]}, {"uuid": "f0ae80f8-ed53-3c8e-afeb-d96a5250b219", "title": "Akebia Therapeutics Inc (AKBA) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges ...", "publisher": "GuruFocus.com", "link": "https://finance.yahoo.com/news/akebia-therapeutics-inc-akba-q3-070910976.html", "providerPublishTime": 1731049750, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/h3ezkB8tk9U4_zK4oWZW6A--~B/aD0xODA7dz0xODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/d3269b7b8a5be249f2c292ab2e570e00", "width": 180, "height": 180, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/4UprAfKJfqgwU.1LsCZeLw--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/us.finance.gurufocus/d3269b7b8a5be249f2c292ab2e570e00", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AKBA"]}, {"uuid": "5a067c43-2037-37da-b03f-a99d65f88360", "title": "New Strong Sell Stocks for November 22nd", "publisher": "Zacks", "link": "https://finance.yahoo.com/news/strong-sell-stocks-november-22nd-085300305.html", "providerPublishTime": 1732265580, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/vtsVt8PEmb10KQ4cnwEJfQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/96776645e0ac7ab203b7d5e3b37251a6", "width": 635, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/B3sMsNX6Xfj2qd6ANCpM1Q--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/zacks.com/96776645e0ac7ab203b7d5e3b37251a6", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ALTG"]}, {"uuid": "bdf1c0e3-f695-30d9-9a22-fda955c5fc73", "title": "Akebia Therapeutics to Present at the 36th Annual Piper Sandler Healthcare Conference", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/akebia-therapeutics-present-36th-annual-130000267.html", "providerPublishTime": 1732539600, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/TC3ZCpWljA1qxdUAc3L0mw--~B/aD0xNjM7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/0ab1720f444c3184a18a33bd946181b8", "width": 400, "height": 163, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/yq1etKy8YADSdY_AR_kE.w--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/0ab1720f444c3184a18a33bd946181b8", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AKBA"]}, {"uuid": "8f1901d9-5d88-33f4-91c6-25ef0a400cbd", "title": "Akebia Therapeutics to Present at the Jefferies London Healthcare Conference", "publisher": "PR Newswire", "link": "https://finance.yahoo.com/news/akebia-therapeutics-present-jefferies-london-130000366.html", "providerPublishTime": 1731416400, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/TC3ZCpWljA1qxdUAc3L0mw--~B/aD0xNjM7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/0ab1720f444c3184a18a33bd946181b8", "width": 400, "height": 163, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/yq1etKy8YADSdY_AR_kE.w--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/prnewswire.com/0ab1720f444c3184a18a33bd946181b8", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["AKBA"]}, {"uuid": "f324f2f3-cae7-3324-9a38-2b2dae7f3470", "title": "Akebia Therapeutics: Q3 Earnings Snapshot", "publisher": "Associated Press Finance", "link": "https://finance.yahoo.com/news/akebia-therapeutics-q3-earnings-snapshot-122155307.html", "providerPublishTime": 1730982115, "type": "STORY", "relatedTickers": ["AKBA"]}]